Oric Pharmaceuticals Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Oric Pharmaceuticals Inc 's ROA in the second quarter of 2026?
Oric Pharmaceuticals Inc recorded a cumulative net loss of $-140 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -33.3%.

However, within the Healthcare sector 443 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3691, from total ROA ranking in the first quarter of 2026 at 4381.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Total Assets Change	34.74 %	95.91 %	49.15 %	47.29 %	-1.82 %
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in million	-140	-135	-129	-135	-137
Return On Assets (TTM)	-33.3 %	-34.21 %	-37.88 %	-43.9 %	-50.21 %
ORIC's Total Ranking	# 3691	# 4381	# 3922	# 4045	# 4097
Total Assets (TTM) in million	407	437	409	433	302
Seq. Total Assets Change	-6.72 %	6.82 %	-5.58 %	43.22 %	35.63 %
Seq. Net Income Change	-	-	-	-	-

ORIC's 5 Years Annual ROA >> Back to ORIC Management Effectiveness >> Compare ORIC ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 170
Sector	# 444
Overall	# 3660

Return On Assets Statistics
High	Average	Low
-3.82 %	-34.65 %	-47.09 %
(Mar 31 2020)		(Jun 30 2025)

Financial Statements
Oric Pharmaceuticals Inc 's Assets	$ 407 million	ORIC's Balance sheet
Oric Pharmaceuticals Inc 's Income	$ -41 million	Quarterly ORIC's Income Statement
ORIC's Income by Division		See ORIC's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	89.56 %	7.8 %	2.27 %	-16.74 %	-0.12 %
Total Assets in million	520	274	254	249	299
Y / Y Net Income Change	-	-	-	-	-
Net Income in million	-129	-128	-101	-89	-79
Annual Return On Assets	-24.91 %	-46.64 %	-39.6 %	-35.84 %	-26.36 %

ORIC's 5 Years Annual ROA >> Back to ORIC Management Effectiveness >> Compare ORIC ROA to its Competitors

More Return On Assets Ratios
ORIC's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
ORIC's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for ORIC's Competitors
Subscribers only: Roa for Oric Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for ORIC's Customers

You may also want to know
ORIC's Roi	ORIC's Inventory Turnover Ratio	ORIC's Growth Rates	ORIC's Dividend Comparisons
	ORIC's Profitability Ratios	ORIC's Asset Turnover Ratio	ORIC's Dividend Growth
ORIC's Roe	ORIC's Valuation Ratios	ORIC's Financial Strength Ratios	ORIC's Dividend Payout Ratio

Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector

ROA

Date modified: 2026-09-12T18:47:46+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.